{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:19:30Z","timestamp":1762917570241},"reference-count":41,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000030","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003635","name":"Health Insurance Review and Assessment Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.vaccine.2015.02.035","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T15:36:52Z","timestamp":1424965012000},"page":"1815-1823","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pandemic influenza A vaccination and incidence of Guillain\u2013Barr\u00e9 syndrome in Korea"],"prefix":"10.1016","volume":"33","author":[{"given":"Changsoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seonkyeong","family":"Rhie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Ryong","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geun-Ryang","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Chul","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Yool","family":"Jun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.02.035_bib0210","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain\u2013Barre syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1055\/s-2007-981686","article-title":"Clinical presentation and course of childhood Guillain\u2013Barre syndrome: a prospective multicentre study","volume":"38","author":"Korinthenberg","year":"2007","journal-title":"Neuropediatrics"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2015.02.035_bib0220","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1086\/513793","article-title":"Clinical and epidemiologic features of Guillain\u2013Barre syndrome","volume":"176","author":"Hughes","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0225","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0230","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1006736","article-title":"Safety and effectiveness of a 2009 H1N1 vaccine in Beijing","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0235","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/aje\/kws197","article-title":"Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009\u20132010","volume":"175","author":"Yih","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0240","doi-asserted-by":"crossref","first-page":"d3908","DOI":"10.1136\/bmj.d3908","article-title":"Guillain\u2013Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case\u2013control study in Europe","volume":"343","author":"Dieleman","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0245","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/aje\/kws196","article-title":"Guillain\u2013Barre syndrome during the 2009\u20132010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans","volume":"175","author":"Wise","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0250","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1016\/j.vaccine.2012.03.013","article-title":"Atypical forms of Guillain\u2013Barre syndrome and H1N1-influenza vaccination","volume":"30","author":"Shaikh","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0255","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/aje\/kws195","article-title":"Risk of confirmed Guillain\u2013Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009\u20132010","volume":"175","author":"Greene","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0260","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jama.2012.7342","article-title":"Risk of Guillain\u2013Barre syndrome following H1N1 influenza vaccination in Quebec","volume":"308","author":"De Wals","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0265","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.vaccine.2013.06.032","article-title":"International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines","volume":"31","author":"Dodd","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0270","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.vaccine.2011.01.007","article-title":"Guillain\u2013Barre syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition","volume":"29","author":"Choe","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0275","doi-asserted-by":"crossref","first-page":"99","DOI":"10.7883\/yoken.65.99","article-title":"Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea","volume":"65","author":"Kim","year":"2012","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0280","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1467-9868.2010.00749.x","article-title":"Fast stable restricted maximum likelihood and marginal likelihood estimation of semiparametric generalized linear models","volume":"73","author":"Wood","year":"2011","journal-title":"J R Stat Soc Ser B"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0290","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00001648-200005000-00016","article-title":"The distributed lag between air pollution and daily deaths","volume":"11","author":"Schwartz","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0295","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1212\/01.wnl.0000310983.38724.d4","article-title":"Guillain\u2013Barre syndrome: incidence and mortality rates in US hospitals","volume":"70","author":"Alshekhlee","year":"2008","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2015.02.035_bib0300","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1093\/infdis\/175.Supplement_1.S151","article-title":"Assessment of Guillain\u2013Barre syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance","volume":"175","author":"Prevots","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0305","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000339248","article-title":"Guillain\u2013Barre syndrome incidence in a large United States cohort (2000\u20132009)","volume":"39","author":"Shui","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0310","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/aje\/kwn310","article-title":"Investigation of the temporal association of Guillain\u2013Barre syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database","volume":"169","author":"Stowe","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3349\/ymj.1989.30.1.81","article-title":"Guillain\u2013Barre syndrome in Korean children","volume":"30","author":"Coe","year":"1989","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0320","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","article-title":"Guillain\u2013Barre syndrome after exposure to influenza virus","volume":"10","author":"Lehmann","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0325","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain\u2013Barre syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0330","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1212\/WNL.51.4.1110","article-title":"The spectrum of antecedent infections in Guillain\u2013Barre syndrome: a case\u2013control study","volume":"51","author":"Jacobs","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0335","doi-asserted-by":"crossref","first-page":"e58827","DOI":"10.1371\/journal.pone.0058827","article-title":"Safety of pandemic (H1N1) 2009 monovalent vaccines in Taiwan: a self-controlled case series study","volume":"8","author":"Huang","year":"2013","journal-title":"PloS ONE"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0340","doi-asserted-by":"crossref","first-page":"e82222","DOI":"10.1371\/journal.pone.0082222","article-title":"Guillain\u2013Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe","volume":"9","author":"Romio","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0345","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/pds.3638","article-title":"Risk of Guillain\u2013Barre syndrome following pandemic influenza A (H1N1) 2009 vaccination in Germany","volume":"23","author":"Prestel","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0350","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(12)62189-8","article-title":"Association between Guillain\u2013Barre syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis","volume":"381","author":"Salmon","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/aje\/kwp345","article-title":"Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project","volume":"171","author":"Greene","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0360","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1016\/j.vaccine.2011.07.129","article-title":"Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003\u20132010","volume":"29","author":"Choe","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0365","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3201\/eid1206.051369","article-title":"Guillain\u2013Barre syndrome, greater Paris area","volume":"12","author":"Sivadon-Tardy","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0370","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1371\/journal.pone.0000344","article-title":"Guillain\u2013Barre syndrome and preceding infection with campylobacter, influenza and Epstein\u2013Barr virus in the general practice research database","volume":"2","author":"Tam","year":"2007","journal-title":"PloS ONE"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0375","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/aje\/kwr072","article-title":"Guillain\u2013Barre syndrome, influenza like illnesses, and influenza vaccination during seasons with and without circulating A\/H1N1 viruses","volume":"174","author":"Grimaldi-Bensouda","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0380","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/594124","article-title":"Guillain\u2013Barre syndrome and influenza virus infection","volume":"48","author":"Sivadon-Tardy","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0385","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00134-010-1895-4","article-title":"Guillain\u2013Barre syndrome related to pandemic influenza A (H1N1) infection","volume":"36","author":"Chaari","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0390","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2105\/AJPH.2013.301651","article-title":"Cumulative risk of Guillain\u2013Barre syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic","volume":"104","author":"Vellozzi","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0395","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1473-3099(14)70716-9","article-title":"Influenza vaccination and Guillain\u2013Barre syndrome","volume":"14","author":"Kwong","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0400","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.vaccine.2012.09.032","article-title":"Autoimmune disorders after immunisation with Influenza A\/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review","volume":"30","author":"Isai","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0405","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.02.035_bib0410","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain\u2013Barre syndrome worldwide. A systematic literature review","volume":"32","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15002248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T22:02:07Z","timestamp":1651356127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15002248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":41,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0264410X15002248"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pandemic influenza A vaccination and incidence of Guillain\u2013Barr\u00e9 syndrome in Korea","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}